Gibraltar: Protected Cell Companies And Series LCC

Last Updated: 29 November 2016
Article by Nigel Feetham

Segregated business forms operate across many jurisdictions around the world including the US and Europe. They are intended to segregate assets and liabilities for specific business transactions. The most familiar is the protected cell company (PCC) but other types of firms in many jurisdictions perform a similar function such as the US series LLC, the Italian regime ('dedicated assets to a specified activity' and 'financing allocated to a specific business activity'), the Luxembourg SICAV and securitisation regimes, the Irish investment fund, the French FCC, and more recently, the UK open-ended investment company (among others). But whereas in Europe the expansion and development of the concept (supported by the powerful insurance and investment sectors and endorsed by local regulators) appears to have gathered momentum, in the US it has yet to achieve the same level of official recognition, and more recently, in respect of the series LLC, the US Fifth Circuit Court of Appeals appeared to be reluctant to rule on the issue.

Insurance portfolio transfers and the PCC

Gibraltar implemented protected cell company legislation in 2001 and was the first European jurisdiction to do so. Since then Malta has implemented a PCC Act and the UK itself has introduced its own regime for open-ended investment funds. Whilst the exact number of companies operating as protected cells across the European Union is not known, it is likely to be over 100 in all jurisdictions and sectors. It is also of note that in Europe a PCC insurance company has the distinct advantage that the EU Insurance Insolvency Directive requires mutual recognition of a local insolvency process (which in the case of the PCC must include a PCC insolvency). The same applies to cross-frontier insolvencies under the European Insolvency Regulations. Therefore as a general rule an EU PCC insolvency should be respected across the EU and this augurs well for PCCs.

The Supreme Court of Gibraltar recently heard two applications; one application for the transfer of the insurance business of a Gibraltar PCC to an EEA insurer under Part I of Schedule 10 of the Financial Services (Insurance Companies) Act, and a separate but consequential application for the transfer of the cellular assets under the Protected Cell Companies Act. The proceedings were held in open court.

The case appears to be the first cross-border portfolio transfer application in respect of the insurance business of an EU PCC to a non-PCC.

Under Gibraltar law a transfer of insurance business from a Gibraltar life insurance company to another insurer requires Gibraltar Supreme Court approval. It should be noted, however, that no court approval is required for portfolio transfers by general insurance companies; only the approval of the local regulator, the Financial Services Commission (FSC), is required in that case and several such transfers have previously been approved by the FSC. The equivalent regime in the UK is the Part VII transfer provisions.

As would be expected, the Gibraltar legislation transposes all the requirements of the relevant EU insurance directives, including in respect of publicity of the application, policyholder notifications, and 'home state' consultation with the relevant EEA regulators. Applications are therefore matters of public record.

Under the court process, the judge is taken through the affidavit evidence by counsel for the applicant, especially the independent actuary's report and each statutory requirement that the applicant has to comply with in order to obtain the order sought.

Policyholders can object to the proposed transfer by contacting the applicant or the regulator, and also, they have a right to object directly to the court. It should be noted, however, that the question of approval of the scheme is one for the court alone.

In this case, the court also had to consider the consequential application for a cell transfer order under the Protected Cell Companies Act. These provisions apply to every PCC regardless whether business is being transferred from an insurance company or not. The PCC would be obliged to obtain the approval of the court before the transfer of the business can be made (save for transfers from cellular assets in the ordinary course of the company's business).

The case is interesting for several reasons. It is the first court application in Gibraltar under Part I of Schedule 10 of the Financial Services (Insurance Companies) Act and under the Protected Cell Companies Act. This should be helpful for the further expansion and development of local portfolio transfers. In some jurisdictions insurers may push back from court approved portfolio transfers in the absence of a local precedent.

Further, the case is important because of the very limited history of cross-border transfers of a PCC to a non-PCC anywhere in the world. What we may now see as a result are portfolio transfers from ordinary companies to PCC insurers in the insurance run-off space where promoters are looking to segregate different portfolios using a PCC. This is where the cellular structure comes into its own.

The other side of the Atlantic – a cautionary tale

Meanwhile, on the other side of the Atlantic, the US Court of Appeals for the Fifth Circuit has recently been given (and missed) the opportunity to provide judicial clarity to another type of segregated business form in the US, known as the series LLC. (When looking at this business form for 'series' read 'cell' and note that a series LLC can have many series just like a PCC can have many cells). The case is Glenn E. Alphonse, Jr. v. Arch Bay Holdings, L.L.C.; Specialized Loan Servicing, L.L.C. (filed 11 December 2013, although the court has determined that this opinion should not be published and is not precedent except for limited circumstances).

I am particularly interested in the series LLC because I discussed US legal developments for this type of firm in the book Protected Cell Companies: a Guide to their Implementation and Use (2nd edition). I noted the lack of judicial authorities in the US, especially regarding the enforcement of the internal firewalls (also known as the statutory ring-fence) in other states, but given the wide spread use of the series LLC I considered it likely that judicial clarification was inevitable.

As an academic I therefore cannot hide my disappointment with the Fifth Circuit opinion. It is not necessary to restate the facts of the case or the court's legal analysis (or lack thereof). It seems clear (and not just to me) that the court appeared to have difficulty in finding an appropriate legal classification for a Delaware Series LLC: "...Series 2010B is a Series LLC, and Series LLCs only exist to represent the interest of the parent LLC, which in this case is Arch Bay." As other commentators have observed, the court's description of Arch Bay Holdings, LLC as the "parent" of "Series 2010B" must be legally wrong, even if it is open to the courts to conclude that the Series 2010B is "a distinct juridical entity". Admittedly, recognition that a series has separate juridical status (at least for certain legal purposes) should aid recognition of series separation by foreign states and countries, and therefore, its internal firewall more likely to be enforced across jurisdictions. Still, that does not make the legal relationship between an LLC and a series that of a parent and subsidiary. The court also described a series LLC as "basically a business entity within a business entity" (which, loosely, is not incorrect).

One could be forgiven for saying that the US court should have grasped the opportunity to provide a much needed judicial precedent. Instead, the question for consideration was remanded back to the US District Court to decide. Essentially, it dodged the question.

Judging the wind

The concept of segregated business structures is indeed very complex. Despite the fact that I have written extensively about the subject matter, I can say unashamedly that I still find it difficult to articulate clearly in oral discussion how they work. And if I find it difficult, it cannot be easy even for lawyers who practice in this business area, and less still for judges who may lack the experience of them at a commercial level. But as I attempted to discuss in my book, similar structures have already attracted multi-jurisdictional recognition through local laws and we are now at the stage of the evolutionary process where the cross-border recognition is the next step. In the US, unlike in Europe where European legislation has come to the aid of cross-border PCC transactions, only judicial authorities can provide the necessary certainty and predictability. It is therefore most unfortunate that the US Court did not do so in the above mentioned case.

My natural apprehension for the series LLC is that they can be used as a cheap alternative to establishing a new corporate entity whereas legislatures around the world have tended to restrict the PCC for more sophisticated uses (especially insurance and investment funds). But, at the same time, US interstate series LLC transactions have become a fact of commercial reality which a court should not ignore, and absent any considerations of fraud or bad faith, they should take a realistic view of the position. This is even more so given the fact that many US States also have PCC legislation and accordingly should recognise a cell type structure.

Squaring the circle over liability

Over the years I have spent a lot of time thinking about cell structures, in particular consideration of the enforcement of the internal firewalls in foreign court proceedings. While judicial clarification would be extremely helpful, the fact that they have been endorsed by regulators and used throughout the world has become a more important factor in the quest for global recognition. Indeed, the absence of judicial decisions has not stopped the concept's expansion or development. But I am increasingly convinced that, notwithstanding cells (of a protected cell company) are not separate legal entities as such, it would help the process of judicial acceptance if a cell was treated, for certain legal purposes at least, as if it was. This is not the same thing as saying that a cell must be a legal person separate from the company (i.e. have 'incorporated' status as in the case of the incorporated cell company). In my view this is neither necessary nor desirable. Rather, it can be treated by the applicable legislation for certain legal purposes as a separate entity.

It should then follow that a foreign court would be more likely to respect the internal firewalls by reference to the greater separation it offers; most importantly, the ring-fence protection in liquidation of its individual cells. This is because if a cell can be legally liquidated as if it was a separate legal entity, the liability of the cell (of a protected cell company) itself would not, in liquidation, be limited in any way; the liability of the cell (like of a limited company) would be unlimited but such liability would be discharged only from its assets. It would be the liability of its members which would be limited, in accordance with the universally accepted insolvency principle, and in liquidation the non-liability of other cells follows from the liability shield as separate legal entities. In my view, the important legal distinction is not the incorporation of a cell, but that the cell could be wound-up as if it was a company in liquidation under the insolvency legislation and that, therefore, for the purposes of the cell liquidation, each cell is endowed with a corporate shield.

Interestingly, this is where the US District Court (which will now have to consider the case again) may have been heading with its legal analysis that a series LLC was (per Judge Helen Berrigan) a "separate juridical entity": according to the court, the correct defendant in this claim should have been "Arch Bay Holdings LLC, Series 2010B" (not Arch Bay Holdings LLC).

If a 'cell', 'series', 'segregated portfolio' (or whatever term is used), as a creation of local statute is treated for certain important legal purposes as a separate juridical entity (despite the fact that for other purposes it is not), that does seem to square the liability circle. In this regard, it is of note that in the case of PCCs, some jurisdictions have introduced ad hoc amendments to the original legislation to provide for cells to be treated as if they were separate companies in relation to certain matters (usually, liquidation and taxation e.g. Gibraltar) despite the fact that it is the PCC that still carries on business as a single legal person. In this sense, one could say a cell has 'quasi corporate status' even if it is not a company in its own right (which should offer a PCC more protection in a foreign court). Indeed, the clear direction of the local legislatures to courts in a foreign state is that a cell of a PCC should be treated as a separate entity for liability purposes.

Whatever the uncertainties in the US might be for a series LLC, back in Europe a PCC established in the EU should also enjoy the protection of the EU insolvency regime. In my view, one of the future growth areas for European cell companies is likely to be in the portfolio transfer opportunities and the insurance run-off market. I also expect to see the expansion of the concept in the Asian region where its uptake has not been noticeable.

"The quest stands upon the edge of a knife. Stray but a little and it will fail. Yet hope remains while the company is true." (The Lord of the Rings).

It is usually the case in jurisdictions with financial centre aspirations that local lawyers pioneer ideas to promote a jurisdiction's competitiveness and the local legislature then implements them by statute. This is often done with a degree of flexibility in the expectation that in the development of local case-law the judiciary will be as flexible as possible within what was originally intended by the legislature. Sometimes the evidence of intention is not always apparent and the legislature has to step in to amend the existing law as courts begin to interpret it beyond the gaps left open by the legislation. If the statute finds favour it is soon adopted by foreign jurisdictions seeking the same competitive advantage for their own financial sector. Others may take longer to persuade as they wait for regulators and courts around the world to resolve any open questions. Whilst a local court can clearly only apply local laws and develop local jurisprudence, in a world where law reports are easily accessible over the internet (especially to the probing mind of the academic who writes about them in equally accessible local journals) this can often influence the development of similar legal concepts by foreign courts. Unfortunately, in the case of segregated business forms (whether PCC, series LLC or other), judicial guidance of any sort has not been there. That spurred the publication of the PCC book but the elusive quest for judicial acceptance of the cellular structure has not yet come to an end. Yet hope remains.

Nigel Feetham is a partner at Hassans law firm and visiting professor at Nottingham Law School, Nottingham Trent University. Nigel is also the author or co-author of a number of books, including Protected Cell Companies: a Guide to their Implementation and Use (2nd edition), co-authored with Professor Grant Jones. He has also consulted widely for clients on protected cell companies, including the Government of Gibraltar and regulators.

www.gibraltarlaw.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Nigel Feetham
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.